Drugmakers set to raise U.S. prices on at least 500 drugs in January--analysis

Exclusive: Drugmakers set to raise U.S. prices on at least 500 drugs in January Drugmakers including Pfizer , Sanofi and Takeda Pharmaceutical plan to raise prices in the United States on more than 500 drugs in early January. Michael Erman,Patrick Wingrove Reuters

NEW YORK, Dec 29 (Reuters) - Drugmakers including Pfizer (PFE.N), Sanofi (SASY.PA) and Takeda Pharmaceutical (4502.T) plan to raise prices in the United States on more than 500 drugs in early January, according to data analyzed by healthcare research firm 3 Axis Advisors.

Excluding different doses and formulations, more than 140 brands of drugs will have their prices raised next month, the data showed.

The expected price hikes come as the pharmaceutical industry gears up for the Biden Administration to publish significantly discounted prices for 10 high-cost drugs in September, and continues to contend with higher inflation and manufacturing costs.

...